A detailed history of Vanguard Group Inc transactions in Lantheus Holdings, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 7,362,969 shares of LNTH stock, worth $603 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
7,362,969
Previous 6,973,141 5.59%
Holding current value
$603 Million
Previous $432 Million 6.0%
% of portfolio
0.01%
Previous 0.01%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

BUY
$51.07 - $68.26 $19.9 Million - $26.6 Million
389,828 Added 5.59%
7,362,969 $458 Million
Q4 2023

Feb 14, 2024

SELL
$55.6 - $77.89 $884,484 - $1.24 Million
-15,908 Reduced 0.23%
6,973,141 $432 Million
Q3 2023

Nov 14, 2023

SELL
$60.27 - $90.75 $11.7 Million - $17.6 Million
-193,933 Reduced 2.7%
6,989,049 $486 Million
Q2 2023

Aug 14, 2023

SELL
$82.41 - $99.65 $14 Million - $16.9 Million
-170,081 Reduced 2.31%
7,182,982 $603 Million
Q1 2023

May 15, 2023

BUY
$47.76 - $82.86 $5.06 Million - $8.78 Million
105,939 Added 1.46%
7,353,063 $607 Million
Q4 2022

Feb 10, 2023

SELL
$48.76 - $77.67 $25.3 Million - $40.2 Million
-517,996 Reduced 6.67%
7,247,124 $369 Million
Q3 2022

Nov 14, 2022

BUY
$61.42 - $86.29 $20 Million - $28.2 Million
326,396 Added 4.39%
7,765,120 $546 Million
Q2 2022

Aug 12, 2022

BUY
$55.54 - $72.65 $94.2 Million - $123 Million
1,696,641 Added 29.55%
7,438,724 $491 Million
Q1 2022

May 13, 2022

BUY
$24.28 - $56.64 $34.5 Million - $80.6 Million
1,422,269 Added 32.92%
5,742,083 $318 Million
Q4 2021

Feb 14, 2022

SELL
$22.54 - $30.44 $1.28 Million - $1.73 Million
-56,685 Reduced 1.3%
4,319,814 $125 Million
Q3 2021

Nov 12, 2021

SELL
$24.23 - $28.59 $138,716 - $163,677
-5,725 Reduced 0.13%
4,376,499 $112 Million
Q2 2021

Aug 13, 2021

BUY
$19.51 - $27.64 $85.5 Million - $121 Million
4,382,224 New
4,382,224 $121 Million

Others Institutions Holding LNTH

About Lantheus Holdings, Inc.


  • Ticker LNTH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 68,741,904
  • Market Cap $5.63B
  • Description
  • Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...
More about LNTH
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.